REQUEST A DEMO
Total
USD $0.00
Search more companies

Mg Pharma Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Mg Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Mg Pharma Company Limited is an enterprise in Thailand, with the main office in Bangkok , Special Governed District of. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on June 01, 1991. There are currently 50 (estimated) people employed by Mg Pharma Company Limited. From the latest financial highlights, Mg Pharma Company Limited reported a net sales revenue drop of 10.97% in 2024. Its total assets decreased by 8.22% over the same period.

Headquarters
11 Ramkhamhaeng Road Soi Ramkhamhaeng 81/1
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10240

Contact Details: Purchase the Mg Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Mg Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the Mg Pharma Company Limited report to view the information.
Incorporation Date:
June 01, 1991
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Mg Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
-10.97%
Total Operating Revenue
-9.1%
Operating Profit
61.15%
EBITDA
61.15%
Net Profit/Loss for the Period
N/A
Total Assets
-8.22%
Total Equity
-35.81%
Operating Profit Margin
1.42%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
46.76%
Quick Ratio
-0.56%
Cash Ratio
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?